RA
Actavia Life Sciences, Inc.
RASP · OTC
$0.00 +0.00% (+$0.00)
Market Cap $385.9K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
1/9Valuation
-
N/A P/E N/A
EV/EBITDA N/A
P/S N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
57 /100
Average ROIC 242.88%
ROA 4,644.72%
Asset turnover 0.00x
Debt
0 /100
High Current ratio 0.05x
Int. coverage -19.86x
Debt/Equity N/A
Stability
32 /100
Unstable Beta -6.96x
EPS volatility 55.32%
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre RASP
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Keeren Shah
Employees
1
Headquarters
New York City